Emerging Trends in Modulation of Transient Receptor Potential Canonical 6 Channels as Therapeutic Targets
Ayush Sharma1, Snehal Patel1, Mithun Singh Rajput1
1Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad, India.
Abstract:
The transient receptor potential canonical (TRPC) channel family includes TRPC6, a nonselective receptor-activated cation channel. Its activation result in Ca2+, Na+ along with other cationic ion influx and the phosphorylation of tyrosine, serine and phosphoinositides regulates TRPC6. The channel is widely distributed and plays physiological role in different body parts such as kidney, lungs, blood vessels, heart, brain, intrinsic cardiac ganglia and eye. It has been determined that TRPC6 is a crucial part of the kidney podocytes. Mutation in TRPC6 gene results in focal segmental glomerulosclerosis. A significant function of TRPC6 is also witnessed in the pathogenesis of various cancers including breast, esophageal, renal, head and neck squamous cell carcinoma. TRPC6 channel is found to be overexpressed in the macrophages of chronic obstructive pulmonary disorder and has a role in cardiac hypertrophy. In last decade many natural, semi synthetic and synthetic pharmaceutical agents modulating TRPC6 activity have been investigated which can be alucrative approach for the prevention and treatment of diseases associated with TRPC6 channel downregulation and upregulation. Therefore, present review aims to summarize the involvement of TRPC6 with its Ca2+ dependent effect in different physiological and pathological conditions with the downregulation as well as upregulation of TRPC6 channel functions and summarizes the progress achieved in those investigations pertaining to modulators of TRP6 channels.
Insights
Transient Receptor Potential Canonical 6 (TRPC6) channels regulate ion influx and are implicated in kidney disease and cancer. Modulating TRPC6 offers a promising therapeutic avenue for various TRPC6-related pathologies.
Area of Science:
- Molecular Biology
- Physiology
- Pharmacology
Background:
- Transient Receptor Potential Canonical 6 (TRPC6) is a nonselective cation channel involved in cellular signaling.
- TRPC6 plays physiological roles in organs like the kidney, heart, and lungs.
- Dysregulation of TRPC6 is linked to diseases such as focal segmental glomerulosclerosis and various cancers.
Purpose of the Study:
- To review the multifaceted roles of TRPC6 channels in physiological and pathological conditions.
- To summarize the Ca2+-dependent effects of TRPC6 in disease pathogenesis.
- To highlight therapeutic strategies targeting TRPC6 modulators.
Main Methods:
- Literature review of studies investigating TRPC6 function.
- Analysis of research on TRPC6 mutations and expression patterns.
- Examination of preclinical and clinical investigations of TRPC6 modulators.
Main Results:
- TRPC6 is crucial in kidney podocytes, with mutations causing kidney disease.
- TRPC6 overexpression is observed in cancers and chronic obstructive pulmonary disorder.
- TRPC6 dysregulation contributes to cardiac hypertrophy.
Conclusions:
- TRPC6 channel activity is vital in maintaining physiological functions.
- Altering TRPC6 activity presents a potential therapeutic strategy for associated diseases.
- Further research into TRPC6 modulators is warranted for disease prevention and treatment.
Related Concept Videos
Mechanically-gated Ion Channels
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:


